| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1899834-30-0 | Methyl 3-tert-butyl-1,2,4-oxadiazole-5-carboxylate | C8H12N2O3 |
| 1902173-16-3 | Spiratisanin A;((1R,2R,4R,9R,10S,12S,13R)-13-hydroxy-5,5,9,13-tetramethyl-2-tetracyclo(10.2.2.01,10.04,9)hexadecanyl) (E)-3-phenylprop-2-enoate | C29H40O3 |
| 1902954-87-3 | Abeprazan hydrochloride;1-(5-(2,4-difluorophenyl)-1-(3-fluorophenyl)sulfonyl-4-methoxypyrrol-3-yl)-N-methylmethanamine hydrochloride | C19H18ClF3N2O3S |
| 1903768-17-1 | (2S,4R)-1-(2-(3-Acetyl-5-(2-methyl-5-pyrimidinyl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-2-pyridinyl)-4-fluoro-2-Pyrrolidinecarboxamide;ACH 0144471; ACH 4471; Danicopan | C26H23BrFN7O3 |
| 1908444-28-9 | Obeticholic Acid Dimer;7-epi-Obeticholic acid 3-obeticholate ester;(4R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-((4R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta(a)phenanthren-17-yl)pentanoyl)oxy-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta(a)phenanthren-17-yl)pentanoic acid | C52H86O7 |
| 1909293-52-2 | (3S,4S)-4-Fluoro-3-pyrrolidinol hydrochloride (1:1) | C4H8FNO.HCl |
| 1909295-00-6 | rac-(4aS,8aR)-Hexahydro-2H-pyrido(4,3-b)(1,4)oxazin-3(4H)-one dihydrochloride | C7H14Cl2N2O2 |
| 1910124-24-1 | N-(2,3-Dihydro-1,3-dimethyl-6-((2R)-2-methyl-1-piperazinyl)-2-oxo-1H-benzimidazol-5-yl)-2-methoxybenzamide | C22H27N5O3 |
| 1911644-32-0 | Ruxolitinib Amide;3-Cyclopentyl-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)propanamide | C17H20N6O |
| 1912400-29-3 | 3-(3-((Trifluoromethyl)thio)phenyl)-1H-pyrazol-5-amine | C10H8F3N3S |
| 1916569-82-8 | (R)-2-Amino-2-(4-bromophenyl)ethanol hydrochloride;(2R)-2-amino-2-(4-bromophenyl)ethanol;hydrochloride | C8H11BrClNO |
| 1916571-90-8 | N-(4,6-Dimethyl-2-pyridinyl)-4-((4-(trifluoromethyl)phenyl)methyl)-1-piperazinecarbothioamide;NCT 503 | C20H23F3N4S |
| 1917333-91-5 | Ibrutinib Impurity 26;3-(4-phenoxyphenyl)-5-((3R)-1-prop-2-enoylpiperidin-3-yl)-4,5,7,9,13-pentazatricyclo(7.4.0.02,6)trideca-1(13),2(6),3,7-tetraen-12-one | C28H26N6O3 |
| 1922121-95-6 | 2-(Dibenzo(b,d)furan-4-yl)-9H-carbazole | C24H15NO |
| 1923833-60-6 | cis-(alphaR)-N-(4-Chlorophenyl)-4-(6-fluoro-4-quinolinyl)-alpha-methylcyclohexaneacetamide | C24H24ClFN2O |
| 1923836-99-0 | 4-(6-Fluoro-4-quinolinyl)cyclohexanone | C15H14FNO |
| 1924596-31-5 | Mal-amido-PEG8-TFP ester;(2,3,5,6-tetrafluorophenyl) 3-(2-(2-(2-(2-(2-(2-(2-(2-(3-(2,5-dioxopyrrol-1-yl)propanoylamino)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)propanoate | C32H44F4N2O13 |
| 1926163-23-6 | Leuprolide Acetate EP Impurity E;N-(1-((1-((1-((1-((1-((1-((5-(diaminomethylideneamino)-1-(2-(ethylcarbamoyl)pyrrolidin-1-yl)-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)amino)-3-hydroxy-1-oxopropan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl)-5-oxopyrrolidine-2-carboxamide;2,2,2-trifluoroacetic acid | C61H85F3N16O14 |
| 1926163-25-8 | Leuprolide Acetate EP Impurity D;(3-((1-((1-((1-((5-(diaminomethylideneamino)-1-(2-(ethylcarbamoyl)pyrrolidin-1-yl)-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)amino)-2-((2-((3-(1H-imidazol-5-yl)-2-((5-oxopyrrolidine-2-carbonyl)amino)propanoyl)amino)-3-(1H-indol-3-yl)propanoyl)amino)-3-oxopropyl) acetate;2,2,2-trifluoroacetic acid | C63H87F3N16O15 |
| 1926163-26-9 | Leuprolide EP Impurity I;(Des-Gly10,D-Pyr1,D-Leu6,Pro-NHEt9)-LHRH Trifluoroacetate;(2R)-N-((2S)-1-(((2S)-1-(((2S)-1-(((2S)-1-(((2R)-1-(((2S)-1-(((2S)-5-(diaminomethylideneamino)-1-((2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl)-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)amino)-3-hydroxy-1-oxopropan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl)-5-oxopyrrolidine-2-carboxamide;2,2,2-trifluoroacetic acid | C61H85F3N16O14 |
| 1927857-61-1 | 4-(Difluoromethyl)-5-(4-((3S)-3-methyl-4-morpholinyl)-6-(4-morpholinyl)-1,3,5-triazin-2-yl)-2-pyridinamine | C18H23F2N7O2 |
| 1928758-79-5 | 6-(Trifluoromethyl)-4(3H)-pteridinone | C7H3F3N4O |
| 1932056-72-8 | tert-butyl (3S,5S)-3-amino-5-fluoropiperidine-1-carboxylate | C10H19FN2O2 |
| 1932499-00-7 | (3r,4r)-Rel-3-amino-1-boc-4-fluoropiperidine | C10H19FN2O2 |
| 1936626-65-1 | 6-(Phenylmethyl)-2-thia-6-azaspiro(3.3)heptane | C12H15NS |
| 1940180-18-6 | 4-chloro-6-(1-methyl-1H-pyrazol-4-yl)pyrazolo(1,5-a)pyrazine | C10H8ClN5 |
| 1942054-60-5 | Brivaracetam Impurity 26;(R)-3-(bromomethyl)hexanoic acid | C7H13BrO2 |
| 1942114-09-1 | alpha-(5-Fluoro-2-hydroxyphenyl)-1,3-dihydro-1-oxo-N-2-thiazolyl-2H-isoindole-2-acetamide;EAI 045 | C19H14FN3O3S |
| 1943733-16-1 | N-(2-(5-Chloro-2-pyridinyl)ethyl)-4-((((4-methoxyphenyl)sulfonyl)amino)methyl)benzamide;YU 238259 | C22H22ClN3O4S |
| 1945965-95-6 | Ropivacaine EP Impurity F;(8as)-2-(2,6-dimethylphenyl)-3,3-dimethylhexahydroimidazo(1,5-a)pyridin-1(5H)-one | C17H24N2O |
| 1946806-94-5 | N-((1,1'-Biphenyl)-4-yl)-3'-(9H-carbazol-9-yl)-(1,1'-biphenyl)-4-amine;N-(4-(3-carbazol-9-ylphenyl)phenyl)-4-phenylaniline | C36H26N2 |
| 1948273-00-4 | (S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethanamine | C12H14N2S |
| 1948273-01-5 | (alphaS)-alpha-Methyl-4-(4-methyl-5-thiazolyl)benzenemethanamine hydrochloride (1:1);(S)-1-(4-(4-Methylthiazol-5-yl)phenyl)ethanamine hydrochloride | C12H14N2S.HCl |
| 1948273-02-6 | E3 ligase Ligand 1A;(2S,4R)-1-((2S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((1S)-1-(4-(4-methyl-1,3-thiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide | C23H32N4O3S |
| 1948273-03-7 | (4R)-3-Methyl-L-valyl-4-hydroxy-N-((1S)-1-(4-(4-methyl-5-thiazolyl)phenyl)ethyl)-L-prolinamide hydrochloride (1:1);E3 ligase Ligand 1 | C23H32N4O3S.HCl |
| 1951441-43-2 | trans-3-Fluorocyclohexanamine HCl;(1R,3R)-3-fluorocyclohexan-1-amine;hydrochloride | C6H13ClFN |
| 1951483-29-6 | 5,6-Dihydro-6,6-dimethyl-2-(2-((1-methyl-1H-pyrazol-5-yl)amino)-4-pyrimidinyl)-5-(2-(4-morpholinyl)ethyl)-4H-thieno(2,3-c)pyrrol-4-one | C22H27N7O2S |
| 1952236-05-3 | N-(2-Chloro-5-(4-((3-chloro-4-fluorophenyl)amino)-6-quinazolinyl)-3-pyridinyl)methanesulfonamide | C20H14Cl2FN5O2S |
| 1952316-43-6 | 4-(8-Amino-3-((2R)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinylbenzamide | C26H23N7O2 |
| 1952360-91-6 | Fmoc-N-amido-PEG12-propionic acid;3-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)propanoic acid | C42H65NO16 |
| 1953133-47-5 | (1R,3R)-1-(2,6-Difluoro-4-((1-(3-fluoropropyl)-3-azetidinyl)amino)phenyl)-β,β-difluoro-1,3,4,9-tetrahydro-3-methyl-2H-pyrido(3,4-b)indole-2-propanol;GDC 9545; Giredestrant; RG 6171; RG-6171; RG6171 | C27H31F5N4O |
| 1955474-17-5 | (S)-1-Phenylpyrrolidin-3-amine hydrochloride | C10H15ClN2 |
| 1955543-57-3 | 2-(3'-(9,9-Dimethyl-9H-fluoren-2-yl)-(1,1'-biphenyl)-3-yl)-4,6-diphenyl-1,3,5-triazine | C42H31N3 |
| 1956356-56-1 | (5Z)-5-((5-(4-Nitrophenyl)-2-furanyl)methylene)-4-oxo-2-thioxo-3-thiazolidinepropanoic acid potassium salt (1:1) | C17H11N2O6S2.K |
| 1956366-10-1 | 4-(5-Chloro-2-((1-methylethyl)amino)-4-pyridinyl)-N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide hydrochloride (1:1) | C21H22Cl2N4O2.HCl |
| 1956380-24-7 | tert-Butyl 6-methylene-4-azaspiro(2.4)heptane-4-carboxylate | C12H19NO2 |
| 1956385-35-5 | 3-Bromo-8-(methylsulfonyl)quinoline | C10H8BrNO2S |
| 1956426-56-4 | N-(2-(((3-(4-Chlorophenyl)-2-propen-1-yl)methylamino)methyl)phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide hydrochloride (1:1) | C26H29ClN2O4S.HCl |
| 1956436-64-8 | Solifenacin Benzoyl (R)-Quinuclidinyl Impurity;(R)-Quinuclidin-3-yl 2-benzoylphenethylcarbamate;((3R)-1-azabicyclo(2.2.2)octan-3-yl) N-(2-(2-benzoylphenyl)ethyl)carbamate | C23H26N2O3 |
| 1958125-89-7 | (R)-2-amino-2-cyclobutylacetic acid hydrochloride;(2R)-2-amino-2-cyclobutylacetic acid;hydrochloride | C6H12ClNO2 |